Vitamin D and the immune system

Norman, 1982, The vitamin D endocrine system: Steroid metabolism, hormone receptors, and biological response (Calcium binding proteins), Endocr Rev, 3, 331, 10.1210/edrv-3-4-331 Simpson, 1980, Characterization of a receptor-like protein for 1,25-dihydroxyvitamin D3 in rat skin, 77, 5822 Eisman, 1979, 1,25-Dihydroxyvitamin D receptor in breast cancer cells, Lancet, II, 1335, 10.1016/S0140-6736(79)92816-2 Colston, 1981, 1,25-Dihydroxyvitamin D3 and malignant melanoma: The presence of receptors and inhibition of cell growth in culture, Endocrinology, 108, 1083, 10.1210/endo-108-3-1083 Frampton, 1983, Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites, Cancer Res, 43, 4443 Bell, 1985, Vitamin D-endocrine system, J Clin Invest, 76, 1, 10.1172/JCI111930 Braidman, 1985, Extra-endocrine functions of vitamin D, Clin Endocrinol, 23, 445, 10.1111/j.1365-2265.1985.tb01103.x Manolagas, 1985, Interactions of 1,25-dihydroxyvitamin D3 and the immune system, Mol Cell Endocrinol, 43, 113, 10.1016/0303-7207(85)90074-7 Abe, 1981, Differentiation of mouse myeloid leukemia cells induced by 1α,25-dihydroxyvitamin D3, 78, 4990 Bar-Shavit, 1981, 1,25-dihydroxyvitamin D3 and the regulation of macrophage function, Calcif Tissue Int, 33, 673, 10.1007/BF02409507 Honma, 1983, 1α,25-Dihydroxyvitamin D3 and 1α-dihydroxy-vitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells, 80, 201 Peacock, 1982, High affinity 1,25-(OH)2 vitamin D3 receptors in a human monocyte-like cell line (U937) and in a cloned human T lymphocyte, 83 Provvedini, 1983, 1,25-Dihydroxyvitamin D3 receptors in human leukocytes, Science, 221, 1181, 10.1126/science.6310748 Bhalla, 1983, Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: Presence in monocytes and induction in T lymphocytes following activation, J Clin Endocrinol Metab, 57, 1308, 10.1210/jcem-57-6-1308 Provvedini, 1986, 1α,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: Effects on immunoglobulin production, J Immunol, 136, 2734, 10.4049/jimmunol.136.8.2734 Sundström, 1976, Establishment and characterization of a human histiocytic lymphoma cell line (U937), Int J Cancer, 17, 565, 10.1002/ijc.2910170504 Gallagher, 1979, Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia, Blood, 54, 713, 10.1182/blood.V54.3.713.713 Koren, 1975, Identification of macrophage-like characteristics in a cultured murine tumor line, J Immunol, 114, 894, 10.4049/jimmunol.114.2_Part_2.894 Warner, 1969, A transplantable myelomonocytic leukemia in BALB/c mice: Cytology, karyotype and muramidase content, J Natl Cancer Inst, 43, 963 Moscicki, 1983, Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte-conditioned medium: Detection of T4 antigen and its presence on normal blood monocytes, J Immunol, 131, 743, 10.4049/jimmunol.131.2.743 Dodd, 1983, Vitamin D metabolites change the phenotype of monoblastic U937 cells, 80, 7538 Radzun, 1983, Monocytic origin of the human hematopoietic cell line U-937 and its convertibility to macrophages evidenced by isoenzyme mapping, Int J Cancer, 31, 181, 10.1002/ijc.2910310208 Amento, 1984, 1α,25-Dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine mononuclear cell factor, J Clin Invest, 73, 731, 10.1172/JCI111266 Amento, 1985, Interleukin 1 production by the human monocyte cell line U937 requires a lymphokine induction signal distinct from interleukin 2 or interferons, J Immunol, 134, 350, 10.4049/jimmunol.134.1.350 Cohen, 1986, 1α,25-Dihydroxy vitamin D3, activates secretion of hydrogen peroxide by human monocytes, J Immunol, 136, 1049, 10.4049/jimmunol.136.3.1049 Roux-Lombard, 1986, Effect of interferon-gamma and 1 alpha,25-dihydroxyvitamin D3 on Superoxide anion, prostaglandins E2, and mononuclear cell factor production by U937 cells, Cell Immunol, 97, 286, 10.1016/0008-8749(86)90399-0 Goodwin, 1979, Cyclic adenosine monophosphate response to prostaglandin E2 on subpopulations of human lymphocytes, J Exp Med, 150, 1260, 10.1084/jem.150.5.1260 Makoul, 1985, Prostaglandin E2 inhibits the activation of cloned T cell hybridomas, J Immunol, 134, 2645, 10.4049/jimmunol.134.4.2645 Goldring, 1986, The adenosine 3':5'-cyclic monophosphate response to prostaglandin E2 is altered in U937 cells in association with maturational events induced by activated T lymphocytes and 1,25-dihydroxyvitamin D3, J Immunol, 136, 3461, 10.4049/jimmunol.136.9.3461 Knudsen, 1986, Prostaglandins post-transcriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate, J Immunol, 137, 3189, 10.4049/jimmunol.137.10.3189 Murao, 1983, Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate, Cancer Res, 43, 4989 McCarthy, 1983, 1,25-Dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells, Leukemia Res, 7, 51, 10.1016/0145-2126(83)90057-7 Bar-Shavit, 1983, Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3, 80, 5907 Reitsma, 1983, Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite, Nature, 306, 492, 10.1038/306492a0 Ball, 1984, Modulation of class I HLA antigens on HL-60 promyelocytic leukemia cells by serum-free medium: Re-Induction by γ-IFN and 1,25-dihydroxyvitamin D3 (calcitriol), J Immunol, 132, 2424, 10.4049/jimmunol.132.5.2424 Mizel, 1978, Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1: I. Enhancement of LAF production by activated T lymphocytes, J Immunol, 120, 1497, 10.4049/jimmunol.120.5.1497 Hodler, 1985, Influence of vitamin D3 metabolites on the production of interleukins 1,2, and 3, Immunobiology, 170, 256, 10.1016/S0171-2985(85)80075-9 Goldman, 1984, Induction of a high phagocytic capability in P388D1, a macrophagelike tumor cell line, by 1α,25-dihydroxyvitamin D3, Cancer Res, 44, 11 Morel, 1986, Interferon-γ-induced Ia expression in WEHI-3 cells is enhanced by the presence of 1,25-dihydroxyvitamin D3, J Immunol, 136, 2181, 10.4049/jimmunol.136.6.2181 Provvedini, 1986, 1,25-Dihydroxyvitamin D3 promotes in vitro morphologic and enzymatic changes in normal human monocytes consistent with their differentiation into macrophages, Bone, 7, 23, 10.1016/8756-3282(86)90148-1 Dinarello, 1984, Interleukin-1, Rev Infect Dis, 6, 51, 10.1093/clinids/6.1.51 Bhalla, 1986, Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 production, Cell Immunol, 98, 311, 10.1016/0008-8749(86)90291-1 Mizel, 1981, Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1), 78, 2474 Haq, 1985, 1,25-Dihydroxyvitamin D3 (calcitriol) suppresses II-2 induced murine thymocyte proliferation, Thymus, 8, 295 Koizumi, 1985, Effect of 1,25-dihydroxyvitamin D3 on cytokine-induced thymocyte proliferation, Cell Immunol, 96, 455, 10.1016/0008-8749(85)90377-6 Polla, 1986, 1,25-Dihydroxyvitamin D3 maintains adherence of human monocytes and protects them from thermal injury, J Clin Invest, 77, 1332, 10.1172/JCI112438 Dimitriu-Bona, 1983, Human mononuclear phagocyte differentiation antigens: 1. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies, J Immunol, 130, 145, 10.4049/jimmunol.130.1.145 Amento, 1986, The influence of 1,25-dihydroxyvitamin D3 on cells of the immune system, 9 Amento, 1986, 1,25-Dihydroxy vitamin D3 (1,25-(OH)2D3) and gamma interferon (IFN-γ) have opposing effects on HLA-DR and Leu M-3 expression by monocyte/macrophages, Arthritis Rheum, 29, S86 Zlotnik, 1983, Characterization of the γ-interferon-mediated induction of antigen-presenting ability in P388D1 cells, J Immunol, 131, 2814, 10.4049/jimmunol.131.6.2814 Kurt-Jones, 1985, Relationship of macrophage Ia and membrane IL 1 expression to antigen presentation, J Immunol, 135, 3652, 10.4049/jimmunol.135.6.3652 Tsoukas, 1984, 1,25-Dihydroxyvitamin D3: A novel immunoregulatory hormone, Science, 224, 1438, 10.1126/science.6427926 Rigby, 1984, Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol), J Clin Invest, 74, 1451, 10.1172/JCI111557 Rigby, 1985, The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: A cell cycle analysis, J Immunol, 135, 2279, 10.4049/jimmunol.135.4.2279 Manolagas, 1986, The antiproliferative effect of calcitriol on human peripheral blood mononuclear cells, J Clin Endocrinol Metab, 63, 394, 10.1210/jcem-63-2-394 Cantrell, 1983, Transient expression of interleukin 2 receptors. Consequences of T cell growth, J Exp Med, 158, 1895, 10.1084/jem.158.6.1895 Robb, 1984, Low and high affinity cellular receptors for interleukin 2: Implications for the level of Tac antigen, J Exp Med, 160, 1126, 10.1084/jem.160.4.1126 Robb, 1983, Direct demonstration of the identity of T cell growth factor binding protein and the Tac antigen, J Exp Med, 158, 1332, 10.1084/jem.158.4.1332 Sharon, 1986, Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity condition, Science, 234, 859, 10.1126/science.3095922 Kurnick, 1979, Long term growth in vitro of human T cell blasts with maintenance of specificity and function, J Immunol, 122, 1255, 10.4049/jimmunol.122.4.1255 Unanue, 1979, Antigen presentation: Comments on its regulation and mechanism, J Immunol, 132, 1, 10.4049/jimmunol.132.1.1 Bhalla, 1984, 1,25-Dihydroxy vitamin D3 inhibits antigen-induced T cell activation, J Immunol, 133, 1748, 10.4049/jimmunol.133.4.1748 Reichel, 1986, Gamma-interferon synthesis of T-lymphocytes is inhibited in vitro by 1,25-dihydroxyvitamin D3, J Bone Miner Res, 1, 15 Torres, 1982, Interleukin 2 regulates immune interferon (IFN-γ) production by normal and suppressor cell cultures, J Immunol, 128, 2217, 10.4049/jimmunol.128.5.2217 Matsui, 1986, 1,25-Dihydroxyvitamin D3-regulated expression of genes involved in human T-lymphocyte proliferation and differentiation, Cancer Res, 46, 5827 Rigby, 1987, Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3: Specific inhibition at the level of messenger RNA, J Clin Invest, 79, 1659, 10.1172/JCI113004 Rigby, 1986, Interleukin 2-independent suppression of T lymphocyte proliferation and transferrin receptor induction by 1,25-dihydroxyvitamin D3 (calcitriol), Clin Res, 34, 505A Provvedini, 1984, 1,25-Dihydroxyvitamin D3 receptors in a subset of mitotically active lymphocytes from rat thymus, Biochem Biophys Res Commun, 121, 277, 10.1016/0006-291X(84)90719-8 Cohen, 1984, Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death, J Immunol, 132, 38, 10.4049/jimmunol.132.1.38 Howard, 1982, Identification of a T cell-derived B cell growth factor distinct from interleukin 2, J Exp Med, 155, 914, 10.1084/jem.155.3.914 Lee, 1986, Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities, 83, 2061 Ohara, 1985, Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1, Nature, 315, 333, 10.1038/315333a0 Lemire, 1984, 1α,25-Dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells, J Clin Invest, 74, 657, 10.1172/JCI111465 Lemire, 1985, 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro, J Immunol, 134, 3032, 10.4049/jimmunol.134.5.3032 Barbour, 1981, Hypercalcemia in an anephric patient with sarcoidosis: Evidence of extrarenal generation of 1,25-dihydroxyvitamin D, N Engl J Med, 305, 440, 10.1056/NEJM198108203050807 Adams, 1983, Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis, J Clin Invest, 72, 1856, 10.1172/JCI111147 Mason, 1984, Vitamin D conversion by sarcoid lymph node homogenate, Ann Int Med, 100, 59, 10.7326/0003-4819-100-1-59 Abe, 1983, 1α,25-Dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism, 80, 5583 Koren, 1985, Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D, J Clin Invest, 76, 2012, 10.1172/JCI112201 Liberman, 1983, Resistance to 1,25-dihydroxyvitamin D: Association with heterogeneous defects in cultured skin fibroblasts, J Clin Invest, 77, 192, 10.1172/JCI110759 Stroder, 1975, 675 Fujita, 1984, T lymphocyte subsets in osteoporosis: Effect of 1-alpha hydroxyvitamin D3, Miner Electrolyte Metab, 10, 375 Tabata, 1986, The effect of 1α,25-dihydroxyvitamin D3 on cell-mediated immunity in hemodialyzed patients, J Clin Endocrinol Metab, 63, 1218, 10.1210/jcem-63-5-1218 Katz, 1984, Immunosuppression as a physiological homeostatic mechanism, Immunol Today, 5, 96, 10.1016/0167-5699(84)90041-0